Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Innovative lifesaving device for patients with advanced heart failure

Bradley Cantley, 41, headed home from UC San Diego Medical Center connected to a lifesaving heart machine called a left ventricular assisted device (LVAD). For patients with advanced heart failure, the mechanical pump rapidly improves circulation throughout the body and serves as a bridge to transplant. Cantley is the first of many patients, locally and globally, who will benefit from the expanded heart surgery program at UC San Diego Health System.

2 Nov 2010

Study finds elderly women at high risk for inappropriate urinary catheter utilization

Elderly women are at high risk for inappropriate urinary catheter utilization in emergency departments, according to a new study in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

2 Nov 2010

Porex sells surgical division to Stryker

Porex Corporation, a portfolio company of Los Angeles-based investment firm Aurora Capital Group, today announced that it has sold its Porex Surgical division to Stryker Corporation.

From Stryker 1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

1 Nov 2010

Stryker acquires Porex Surgical

Stryker Corporation announced today the acquisition of privately-held Porex Surgical, a division of Porex Corporation. Porex Surgical is a developer, manufacturer and distributor of bioimplantable porous polyethylene products (PPE) for use primarily in reconstructive surgery of the head and face.

From Stryker 30 Oct 2010

Stryker enters agreement to acquire assets of Neurovascular division of Boston Scientific

Stryker Corporation announced today a definitive agreement to acquire the assets of the Neurovascular division of Boston Scientific in an all cash transaction for $1.5 billion, which includes $100 million of milestone payments.

From Stryker 29 Oct 2010

Disinfection cap dispensing 70% isopropyl alcohol effectively disinfects IV needleless connectors

A study and review performed by clinicians of PICC Excellence, Inc. found a disinfection cap that dispenses 70% isopropyl alcohol is effective in disinfecting IV needleless connectors after five minutes. The study shows that if a needleless connector is covered and bathed in alcohol by the disinfection cap, no drying time is required to kill nearly all pathogens on the connector.

28 Oct 2010

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.

28 Oct 2010

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).

28 Oct 2010

Study finds passive safety engineered devices effective for NSI prevention

A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

From B. Braun Melsungen AG 27 Oct 2010

Boston Scientific announces completion of Asthmatx acquisition

Boston Scientific Corporation today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California. The transaction follows the definitive agreement announced on September 20. Under the terms of the agreement, Boston Scientific purchased all outstanding Asthmatx shares for a total of $193.5 million. Additional payments of up to $250 million are contingent upon achievement of specified revenue-based criteria through 2019. Asthmatx is now an indirect, wholly-owned subsidiary of Boston Scientific.

27 Oct 2010

Knowledge gaps and unjustified fear common among caregivers of children with MRSA

Knowledge gaps and fear - some of it unjustified - are common among the caregivers of children with a drug-resistant staph bacterium known as MRSA, according to the results of a small study from the Johns Hopkins Children Center. These caregivers thirst for timely, detailed and simple information, the researchers add.

26 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, delivered two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Vancouver, Canada.

25 Oct 2010

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

21 Oct 2010

Stereotaxis launches Odyssey Interventional Network portal for global cardiovascular community

Stereotaxis, Inc. announced today that it launched the Odyssey Interventional Network, a training and educational video sharing web portal for the global cardiovascular community. The portal will showcase innovative electrophysiology (EP) and interventional cardiology (IC) procedures from leading centers around the world.

21 Oct 2010

Vascular Solutions acquires EXPRO Elite and MICRO Elite snare products from Radius

Vascular Solutions, Inc. today announced that it has acquired the assets related to the EXPRO Elite™ and MICRO Elite™ snare products from Radius Medical Technologies, Inc. and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the EXPRO Elite™ and MICRO Elite™ snares in the U.S. under a distribution relationship with Radius since 2008, while in international markets Radius has been selling the products through a network of independent distributors.

21 Oct 2010

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott today announced financial results for the third quarter ended Sept. 30, 2010.

20 Oct 2010

UC awarded $2.1 million technology award to develop next generation brain monitors

The U.S. Department of Defense has awarded researchers at the University of Cincinnati (UC) a $2.1 million Advanced Technology/Therapeutic Development Award to develop the next generation of brain monitors.

19 Oct 2010

Catheter News and Research

Further Reading

Innovative lifesaving device for patients with advanced heart failure

Study finds elderly women at high risk for inappropriate urinary catheter utilization

Porex sells surgical division to Stryker

Vascular Pathways closes $14 million Series B equity financing round

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Stryker acquires Porex Surgical

Stryker enters agreement to acquire assets of Neurovascular division of Boston Scientific

Disinfection cap dispensing 70% isopropyl alcohol effectively disinfects IV needleless connectors

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Study finds passive safety engineered devices effective for NSI prevention

Boston Scientific announces completion of Asthmatx acquisition

Knowledge gaps and unjustified fear common among caregivers of children with MRSA

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Stereotaxis launches Odyssey Interventional Network portal for global cardiovascular community

Vascular Solutions acquires EXPRO Elite and MICRO Elite snare products from Radius

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

UC awarded $2.1 million technology award to develop next generation brain monitors

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News